Antenatal dexamethasone for early preterm birth in low-resource countries.

Natl Med J India

Department of Paediatrics, WHO Collaborating Centre for Training and Research in Newborn Care, All India Institute of Medical Sciences, New Delhi, India.

Published: December 2021

Download full-text PDF

Source
http://dx.doi.org/10.25259/NMJI_916_20DOI Listing

Publication Analysis

Top Keywords

antenatal dexamethasone
4
dexamethasone early
4
early preterm
4
preterm birth
4
birth low-resource
4
low-resource countries
4
antenatal
1
early
1
preterm
1
birth
1

Similar Publications

Signs of virilization, such as clitoromegaly, labio-scrotal fusion, and urogenital sinus may be observed in females with 21-hydroxylase deficiency (21-OHD) and other rare virilizing forms of congenital adrenal hyperplasia (CAH). This makes sex determination difficult, and multiple reconstructive surgeries in the postnatal period may be required. As 21-OHD is an autosomal recessive disease, the chance of any child being affected is one in four and so only one in eight will be an affected female.

View Article and Find Full Text PDF

Background Babies born between 37 weeks +0 days and 38 weeks +6 days by scheduled caesarean delivery before the onset of labour are more prone to developing respiratory complications than babies delivered between 39 weeks +0 days and 40 weeks +0 days. Antenatal corticosteroids have been used in preterm births for lung maturity. The advantages of administering antenatal corticosteroids before a scheduled caesarean delivery in the early term remain a subject of debate.

View Article and Find Full Text PDF

Antenatal steroids elicited neurodegenerative-associated transcriptional changes in the hippocampus of preterm fetal sheep independent of lung maturation.

BMC Med

August 2024

Department of Obstetrics and Gynaecology, Yong Loo Lin School of Medicine, National University of Singapore, 1E Kent Ridge Road NUHS Tower Block, Level 12, Singapore, 119228, Singapore.

Background: Antenatal steroid therapy for fetal lung maturation is routinely administered to women at risk of preterm delivery. There is strong evidence to demonstrate benefit from antenatal steroids in terms of survival and respiratory disease, notably in infants delivered at or below 32 weeks' gestation. However, dosing remains unoptimized and lung benefits are highly variable.

View Article and Find Full Text PDF
Article Synopsis
  • Researchers looked at how synthetic glucocorticoids (sGCs) given to pregnant women at risk of pre-term labor could affect when they actually go into labor.
  • They reviewed many studies and found mixed results; some women gave birth earlier when treated with sGCs while others did not.
  • The scientists suggest that sGCs might cause some women to go into labor sooner, but they think more careful research is needed to understand this better.
View Article and Find Full Text PDF

Background: The use of antenatal corticosteroids beyond 34 weeks of gestation to prevent certain neonatal complications remains a debate. This study sought to determine the effect of the use of antenatal corticosteroids in late preterm delivery on neonatal morbidity.

Methodology: It was a randomized double-blind placebo and active-controlled multi-arm trial.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!